Detected ·
Alethio Therapeutics
€80.46MSeries A
Alethio Therapeutics, a University of Oxford spin-out developing targeted therapies for blood cancers (MPNs), raised €80.46M in a Series A round.
- Website
- —
- —
- Amount
- €80 460 000 EUR
- Stage
- Series A
- Event
- Funding round
- Detected
- 2026-11-10 08:07:24 UTC
- Signal ID
- ab5db2c9-6d4a-4ada-9b11-e3f47c6dcc40
As the API returns it
{
"id": "ab5db2c9-6d4a-4ada-9b11-e3f47c6dcc40",
"created_at": "2026-11-10T08:07:24.081274Z",
"company_name": "Alethio Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 80460000,
"funding_currency": "EUR",
"funding_stage": "series_a",
"message": "*Alethio Therapeutics, a University of Oxford spin-out developing targeted therapies for blood cancers (MPNs), raised €80.46M in a Series A round.*"
}